Yes, it is concerning. That was just a sample of 35 companies. If that situation holds true for many of the others that aren't inspected, then it implies that the situation is of a larger concern than mentioned in the sample. Yes, it is a concern. Health Canada can speak to how it is going to respond to those findings, and recommendation 2.47.
Member Desjarlais raised an issue a few times, and I don't think it's been addressed. I want to point him to the Nagoya Protocol on access and Benefit-Sharing under the UN Convention on Biodiversity. There's a huge international debate about the issues of biopiracy, bioprospecting, scientific imperialism, and so on. It's very important in the Canadian context. That's just so it doesn't appear that this issue has been left unaddressed.